143 related articles for article (PubMed ID: 22777334)
1. Pharmacokinetic modelling of N-(4-[(18)F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation.
Di Gialleonardo V; Signore A; Willemsen AT; Sijbesma JW; Dierckx RA; de Vries EF
Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1551-60. PubMed ID: 22777334
[TBL] [Abstract][Full Text] [Related]
2. N-(4-18F-fluorobenzoyl)interleukin-2 for PET of human-activated T lymphocytes.
Di Gialleonardo V; Signore A; Glaudemans AW; Dierckx RA; De Vries EF
J Nucl Med; 2012 May; 53(5):679-86. PubMed ID: 22499614
[TBL] [Abstract][Full Text] [Related]
3. Development and Evaluation of Interleukin-2-Derived Radiotracers for PET Imaging of T Cells in Mice.
van der Veen EL; Suurs FV; Cleeren F; Bormans G; Elsinga PH; Hospers GAP; Lub-de Hooge MN; de Vries EGE; de Vries EFJ; Antunes IF
J Nucl Med; 2020 Sep; 61(9):1355-1360. PubMed ID: 32111688
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.
Hartimath SV; Manuelli V; Zijlma R; Signore A; Nayak TK; Freimoser-Grundschober A; Klein C; Dierckx RAJO; de Vries EFJ
Oncotarget; 2018 Jan; 9(6):7162-7174. PubMed ID: 29467958
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy.
van de Donk PP; Wind TT; Hooiveld-Noeken JS; van der Veen EL; Glaudemans AWJM; Diepstra A; Jalving M; de Vries EGE; de Vries EFJ; Hospers GAP
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4369-4376. PubMed ID: 34076745
[TBL] [Abstract][Full Text] [Related]
6. Clinical-grade N-(4-[
van der Veen EL; Antunes IF; Maarsingh P; Hessels-Scheper J; Zijlma R; Boersma HH; Jorritsma-Smit A; Hospers GAP; de Vries EGE; Lub-de Hooge MN; de Vries EFJ
EJNMMI Radiopharm Chem; 2019 Jul; 4(1):15. PubMed ID: 31659562
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Quantification of ERĪ² Expression by Pharmacokinetic Modeling: Studies with
Antunes IF; Willemsen ATM; Sijbesma JWA; Boerema AS; van Waarde A; Glaudemans AWJM; Dierckx RAJO; de Vries EGE; Hospers GAP; de Vries EFJ
J Nucl Med; 2017 Nov; 58(11):1743-1748. PubMed ID: 28705918
[TBL] [Abstract][Full Text] [Related]
8. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
Ory D; Postnov A; Koole M; Celen S; de Laat B; Verbruggen A; Van Laere K; Bormans G; Casteels C
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575
[TBL] [Abstract][Full Text] [Related]
9. An Improved Synthesis of N-(4-[
Khanapur S; Yong FF; Hartimath SV; Jiang L; Ramasamy B; Cheng P; Narayanaswamy P; Goggi JL; Robins EG
Molecules; 2021 Mar; 26(6):. PubMed ID: 33808813
[TBL] [Abstract][Full Text] [Related]
10. In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.
Khayum MA; Doorduin J; Antunes IF; Kwizera C; Zijlma R; den Boer JA; Dierckx RA; de Vries EF
Nucl Med Biol; 2015 Jun; 42(6):561-9. PubMed ID: 25735222
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
12. Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
Verwer EE; Oprea-Lager DE; van den Eertwegh AJ; van Moorselaar RJ; Windhorst AD; Schwarte LA; Hendrikse NH; Schuit RC; Hoekstra OS; Lammertsma AA; Boellaard R
J Nucl Med; 2015 Mar; 56(3):365-71. PubMed ID: 25678491
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis.
Kropholler MA; Boellaard R; Elzinga EH; van der Laken CJ; Maruyama K; Kloet RW; Voskuyl AE; Dijkmans BA; Lammertsma AA
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):624-31. PubMed ID: 19043704
[TBL] [Abstract][Full Text] [Related]
15. N-[
Hartimath SV; Khayum MA; van Waarde A; Dierckx RAJO; de Vries EFJ
Mol Imaging Biol; 2017 Aug; 19(4):570-577. PubMed ID: 27896627
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 4'-[methyl-11C]thiothymidine in a rodent tumor and inflammation model.
Toyohara J; Elsinga PH; Ishiwata K; Sijbesma JW; Dierckx RA; van Waarde A
J Nucl Med; 2012 Mar; 53(3):488-94. PubMed ID: 22315439
[TBL] [Abstract][Full Text] [Related]
17. Simplified Methods for Quantification of
Jansen BHE; Yaqub M; Voortman J; Cysouw MCF; Windhorst AD; Schuit RC; Kramer GM; van den Eertwegh AJM; Schwarte LA; Hendrikse NH; Vis AN; van Moorselaar RJA; Hoekstra OS; Boellaard R; Oprea-Lager DE
J Nucl Med; 2019 Dec; 60(12):1730-1735. PubMed ID: 31000583
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of [11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis.
Doorduin J; Klein HC; de Jong JR; Dierckx RA; de Vries EF
Nucl Med Biol; 2010 Jan; 37(1):9-15. PubMed ID: 20122662
[TBL] [Abstract][Full Text] [Related]
19. Quantification of [
van de Stadt EA; Yaqub M; Lammertsma AA; Poot AJ; Schober PR; Schuit RC; Smit EF; Bahce I; Hendrikse NH
EJNMMI Res; 2020 Aug; 10(1):97. PubMed ID: 32804306
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic Modeling of [
Ghazanfari N; van Waarde A; Doorduin J; Sijbesma JWA; Kominia M; Koelewijn M; Attia K; Willemsen ATM; Visser TJ; Heeres A; Dierckx RAJO; de Vries EFJ; Elsinga PH
Mol Pharm; 2022 Mar; 19(3):918-928. PubMed ID: 35170965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
